Primary treatment of zygomycosis with liposomal amphotericin B: Analysis of 28 cases

69Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lipid formulations of amphotericin B are increasingly used in lieu of deoxycholate amphotericin B for primary treatment of zygomycosis, but little is known about the efficacy of the former antifungal in treating this fungal disease. We therefore undertook an analysis of a case series of all patients with zygomycosis who received L-AMB for primary antifungal therapy in five major mid-Atlantic medical centers. Among the categories of variables studied were demographics, methods of diagnosis, microbiology, sites of infection, global responses, and survival. The median patient age was 44 years and 71% were male. Immunosuppressive hematological disorders (54%) were the most common underlying condition. Pulmonary disease constituted 50% of infections, sinus infection 29%, and cutaneous disease 18%. Members of the genus Rhizopus were the most common recovered agents. Success as defined by complete or partial positive response was noted in 32% of the cases. Concomitant surgery was performed in 46% of the cases, with similar response rates (31%). Overall survival was 39%. L-AMB was effective as primary therapy in only some patients in this cohort of highly immunocom-promised individuals with invasive zygomycosis underscoring the importance of host response and the need for further advances for treatment of this lethal infection. © 2010 ISHAM.

References Powered by Scopus

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

4373Citations
N/AReaders
Get full text

Epidemiology and outcome of zygomycosis: A review of 929 reported cases

2276Citations
N/AReaders
Get full text

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1335Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

1110Citations
N/AReaders
Get full text

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

551Citations
N/AReaders
Get full text

Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis

543Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shoham, S., Magill, S. S., Merz, W. G., Gonzalez, C., Seibel, N., Buchanan, W. L., … Walsh, T. J. (2010). Primary treatment of zygomycosis with liposomal amphotericin B: Analysis of 28 cases. Medical Mycology, 48(3), 511–517. https://doi.org/10.3109/13693780903311944

Readers over time

‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

52%

Researcher 7

26%

Professor / Associate Prof. 5

19%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 18

75%

Agricultural and Biological Sciences 3

13%

Biochemistry, Genetics and Molecular Bi... 2

8%

Chemistry 1

4%

Save time finding and organizing research with Mendeley

Sign up for free
0